首页 | 本学科首页   官方微博 | 高级检索  
     


An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer
Authors:Alessandra Anna Prete  Letizia Procaccio  Francesca Bergamo  Cosimo Rasola  Floriana Nappo  Vittorina Zagonel  Sara Lonardi
Affiliation:1.Oncology Unit 1, Veneto Institute of Oncology IOV–IRCCS, 35128 Padua, Italy; (L.P.); (F.B.); (C.R.); (F.N.); (V.Z.);2.Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padua, Italy;3.Oncology Unit 3, Veneto Institute of Oncology IOV–IRCCS, 35128 Padua, Italy
Abstract:
Keywords:olaparib   metastatic pancreatic cancer   BRCA   PARP inhibitors
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号